Cambridge Healthtech Institute’s 5th Annual
Clinical Biospecimens Technology and Outsourcing
Managing Specimens and Partnering with Labs & Biorepositories
February 20-21, 2020
The availability of high-quality biological specimens, laboratory access, and diagnostics services are of the utmost importance for biomarker-driven clinical trials and future research. The complexity and number of samples collected and analyzed during
studies has increased steadily over the years and we need to come up with best practices, operational models, and IT solutions to deal with this volume and complexity. CHI’s 5th Annual Clinical Biospecimens and Central Lab Solutions conference
brings together leading experts, clinical trial sponsors, and CROs to discuss challenges and identify actions to improve infrastructure for biomarker-driven clinical trials.
Arrive early and attend Part 1 (Wed - Thurs): Clinical Biomarkers Operations and Innovation
Challenges of Clinical Specimen Management in the Era of Precision Medicine
Debra Reinhard, Head, TM Enabling Solutions, Translational Medicine, Bristol-Myers Squibb Co.
Title to be Announced
Mohan Bangalore, PhD, MBA, Global Head BioAssets, Protein, Cellular & Structural Sciences (PCSS), Medicine Design, R&D, GlaxoSmithKline
Performing Research during a Clinical Trial: Managing the Biospecimens
Matthew Nguyen, Manager, Clinical Biospecimen Operations, BioMarin Pharmaceutical Inc.
Clinical Sample Vendor Qualification and Process Management
Mary Zuniga, Consultant, Translational Science, Immunology, Eli Lilly & Co.
Biobanking Strategy Using Advanced Informatics to Enable Scientific Discovery and Innovation
Lynn Wetherwax, Senior Manager, BSM & Biobank, Research Operations, Amgen
Overview on Technologies and Approaches for Biospecimen Management
Brenda Yanak, Principal, Clinical Transformation Partners
The Connected Patient: A "One Stop Shop" for Trial Information and Data
Megan McBride, MPH, Associate Director, Janssen Clinical Innovation, GCDO, R&D, Janssen, The Pharmaceutical Companies of Johnson & Johnson
INTERACTIVE PANEL: Making Virtual Real: Taking Trials Forward
Moderator: Jane Myles, Head, Operational Intelligence and Innovation, Roche
Sharin Roth, Director, Clinical Pharmacology, Bioanalysis, Otsuka Pharmaceutical Companies
Bardia Akbari, PharmD, Senior Vice President, Clinical Operations, Science37